Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers

Status:
Completed

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.

Phase 2

Vanda Pharmaceuticals